Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype

• Séverine Mercier-Delarue,

  Affiliation Department of Microbiology, Saint Louis University Hospital, Paris, France

  ⨯
• Christine Durier,

  Affiliation INSERM—SC10-US19,Villejuif, France

  ⨯
• Nathalie Colin de Verdière,

  Affiliation Department of Infectious Diseases, Saint Louis University Hospital, Paris, France

  ⨯
• Jean-Dominique Poveda,

  Affiliation Laboratoire CERBA Saint-Ouen-L'aumône- France, Saint-Ouen-L'aumône, France

  ⨯
• Vincent Meiffrédy,

  Affiliation INSERM—SC10-US19,Villejuif, France

  ⨯
• Maria Dolores Fernandez Garcia,

  Affiliation INSERM U944 -UMR 7212, Saint Louis University Hospital, Paris, France

  ⨯
• Stéphane Lastère,

  Affiliation Department of Medical Biology, Centre Hospitalier de Polynésie Française, Papeete–Tahiti, French Polynesia

  ⨯
• Raymond Césaire,

  Affiliation Department of Viro-Immunology, University Hospital of Fort de France, Fort de France- Martinique, French West Indies

  ⨯
• Jean-Claude Manuggera,

  Affiliation Institut Pasteur, Environment and Infectious Risks Research and Expertise Unit, Laboratory for Urgent Response to Biological Threats, Paris, France

  ⨯
• Jean-Michel Molina,

  Affiliation Department of Infectious Diseases, Saint Louis University Hospital, Paris, France

  ⨯
• Ali Amara,

  Affiliation INSERM U944 -UMR 7212, Saint Louis University Hospital, Paris, France

  ⨯
• François Simon

  * E-mail: francois.simon@aphp.fr

  Affiliation Department of Microbiology, Saint Louis University Hospital, Paris, France

  http://orcid.org/0000-0002-4345-6249

  ⨯